Quantcast

Latest Parkinson's disease Stories

2014-09-08 08:31:52

Kazutoshi Mori and Peter Walter for discoveries concerning the unfolded protein response--an intracellular quality-control system that detects harmful misfolded proteins in the endoplasmic reticulum and signals the nucleus to carry out corrective measures. NEW YORK, Sept. 8, 2014 /PRNewswire/ -- The Albert and Mary Lasker Foundation today announced the winners of the 2014 Lasker Awards: Kazutoshi Mori and Peter Walter for basic medical research; Alim Louis Benabid and Mahlon R....

2014-09-03 23:03:55

Live with Optimism,to help Ease the Burden - Find the Cure New York, New York (PRWEB) September 03, 2014 "I have Parkinson’s, but Parkinson’s does not have me." These compelling words are from Elke, a person living with Parkinson’s disease (PD) and a participant in the American Parkinson Disease Association’s (APDA) Live with Optimism new Public Service Announcement (PSA). APDA will host two exclusive screening events, one September 11th in Newport Beach, California...

2014-09-03 12:30:29

Continuous levodopa therapy with ND0612H has the potential to prevent or delay the need for surgical intervention in patients with severe stage Parkinson's disease REHOVOT, Israel, September 3, 2014 /PRNewswire/ -- NeuroDerm Ltd., a clinical stage pharmaceutical company developing drugs for central nervous system (CNS) diseases, today announced that the first patients with severe Parkinson's disease have been enrolled and dosed in a Phase IIa trial of ND0612H. ND0612H is a...

2014-09-02 12:29:37

NEW YORK, Sept. 2, 2014 /PRNewswire-USNewswire - The Bachmann-Strauss Dystonia & Parkinson Foundation will be featured in a large window display at 10 Rockefeller Center throughout the month of September, showcasing its call to action--"Help Raise Awareness and Get Proper Care." This opportunity to inform the public about dystonia, a debilitating movement disorder affecting some 500,000 men, women and children in North America, was made possible by a generous donation from EHE...

2014-08-21 16:24:23

REHOVOT, Israel, August 21, 2014 /PRNewswire/ -- NeuroDerm [http://www.neuroderm.com ] Ltd., a clinical stage pharmaceutical company developing drugs for central nervous system (CNS) diseases, today announced that it has signed definitive investment agreements for a $16 million financing round led by certain of its existing investors with the participation of new investors, including The Elias Group. The company plans to use the funding to further the clinical and regulatory...

Premiere Of Universal Pictures "Man Of the Year" - Arrivals
2014-08-19 05:17:09

Rayshell Clapper for redOrbit.com - Your Universe Online On August 11, 2014, people were rocked by the news that Robin Williams had committed suicide by asphyxiation. He hung himself according to one CNN article. For many, the shock was too confusing. Williams helped the world through his stage performances, shows, and movies. He did charity work, entertained the troops, and spread laughter to many. His sudden suicide hurt many. A Huffington Post report included a written statement from...

parkinsons dopamine
2014-08-18 15:08:09

Lee-Ann Donegan, Penn Medicine Study Examined Patients Over First Two Years of Treatment New Penn Medicine research shows that neuropsychiatric symptoms such as depression, anxiety and fatigue are more common in newly diagnosed Parkinson’s disease (PD) patients compared to the general population. The study also found that initiation of dopamine replacement therapy, the most common treatment for PD, was associated with increasing frequency of impulse control disorders and excessive...

2014-08-12 08:31:15

NEW YORK, Aug. 12, 2014 /PRNewswire-USNewswire/ -- Research projects from five groups active in Parkinson's research comprise the 2014 first half (1H 2014) of The Michael J. Fox Foundation for Parkinson's Research (MJFF) Partnering Program. Among the most promising in the MJFF portfolio, Partnering Program projects are presented directly to industry groups who may wish to invest in further development. By connecting industry leaders with those studies ripe for investment, the...

2014-08-05 16:27:31

GRAND RAPIDS, Mich., Aug. 5, 2014 /PRNewswire/ -- Van Andel Research Institute (VARI) is scheduled to host Rallying to the Challenge, a meeting which highlights the many ways people with Parkinson's disease can impact the clinical trial process and accelerate access to new Parkinson's disease treatments. http://photos.prnewswire.com/prnvar/20140417/76339 The meeting will take place during the third annual Grand Challenges in Parkinson's Disease symposium, one of the most...

2014-08-05 12:32:03

NEW YORK, Aug. 5, 2014 /PRNewswire-USNewswire/ -- Researchers need to know the genetic profiles of their study participants to understand more about how certain mutations manifest disease. But do the participants have to know? A group of 35 Parkinson's disease (PD) researchers published today in Genetics of Medicine the different answers to that question among sites investigating mutations in the LRRK2 gene, the greatest known genetic contributor to PD. Investigators from The Michael...


Word of the Day
reremouse
  • A bat.
The word 'reremouse' comes from Middle English reremous, from Old English hrēremūs, hrērmūs ("bat"), equivalent to rear (“to move, shake, stir”) +‎ mouse.
Related